Abstract
Summary
Hydrodextran was prepared by high-pressure catalytic hydrogenation of dextran. The 6% solution prepared for intravenous use was found to be essentially stable over a 6-month period of storage. The preliminary studies on blood level and urine excretion showed no specific effect from hydrogenation of the terminal groups of the dextran chain.
Get full access to this article
View all access options for this article.